1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden
(
- Contribution to journal › Article
-
Mark
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Variations in the practice of molecular radiotherapy and implementation of dosimetry : results from a European survey
(
- Contribution to journal › Article
-
Mark
Dosimetry-based treatment planning for molecular radiotherapy : A summary of the 2017 report from the Internal Dosimetry Task Force
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re
(
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
- 2013
-
Mark
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
(
- Contribution to journal › Article